sleepQ+ is the most effective over-the-counter product for preventing snoring, mild sleep apnoea, sleep disturbance and dry mouth, caused by mouth breathing during sleep. sleepQ+ also prevents mouth breathing or venting during CPAP therapy without causing nasty side effects like headaches, skin redness or pressure marks often associated with chin straps. Preventing mouth breathing or venting is a simple way to improve CPAP compliance because patients can then lower their CPAP pressure, reduce dryness in the mouth and throat (even with a full face mask), visit the bathroom less often during the night and avoid heavy sinus congestion in the morning.
For those patients with limited tolerance of CPAP or dental appliances, sleepQ+ is an excellent follow-on therapy each night to prevent snoring, dry mouth and sinus pressure caused by oral breathing.
By offering patients sleepQ+, sleep clinicians can finally provide a complete service to primary snorers and sufferers of mild sleep apnoea who are usually looking for a low cost, over-the-counter solution until the problem becomes more complex or develops into OSA.
Connecting With The Elusive Undiagnosed OSA Population
It is well recognized that the biggest hurdle to growth in the CPAP industry is the difficulty in connecting with the undiagnosed OSA population despite the fact that potential patients are clearly identifiable by virtue of their call for help when sleeping: they snore. Snoring is the cardinal symptom of OSA, which makes snorers the largest identifiable pool of the undiagnosed OSA population. Therefore, the most effective strategy for sleep clinicians to connect with and bring potential OSA patients into the clinic for evaluation is to offer an OTC, low cost snoring product to meet the needs of primary snorers looking for a simple but effective solution. As sleep clinicians have discovered, the majority of snorers who present to sleep clinics have not developed OSA, or are unwilling to consider CPAP therapy or dental devices for relief from primary snoring or mild sleep apnoea. If the valuable link to these potential CPAP consumers is effectively lost as they walk out the door, when they eventually develop OSA, as many do, the clinician must invest further funds to entice them back again, or lose them to a competitor.
Offering an effective, low cost, OTC snoring product at the clinic provides the opportunity to initiate and maintain contact with a younger snoring demographic (who generally perceive sleep apnoea and CPAP therapy as issues for older people) and to nurture patient relationships during repeat visits for more product. SleepQ+ is designed to fail in the event the user forcibly opens their mouth when gasping during sleep making it a first-line indicator of potential OSA in snorers if the product consistently fails to maintain lip closure, which provides the clinician with the opportunity to check for OSA, build a database of future OSA patients and be the appliance provider-of-choice when the time for CPAP therapy arrives.
By giving our customers the option to purchase sleepQ+ online or from their closest sleep clinic we are helping sleep clinicians break through the barrier to the elusive undiagnosed OSA population to ensure a greater flow of patients to clinics for regular screening of OSA together with follow-up care and support at each step towards purchasing CPAP equipment.
sleepQ+ is registered with the Australian Therapeutic Goods Administration (TGA), Health Canada and Medsafe NZ as a class 1 medical device for preventing involuntary mouth breathing during sleep.
To arrange your supply of this unique product at our wholesale rate or for more information email us at firstname.lastname@example.org.
No products found in this collection
Have you tried SleepQ+ yet?